InvestorsHub Logo
Followers 972
Posts 383062
Boards Moderated 5
Alias Born 06/24/2011

Re: None

Monday, 01/26/2015 12:13:19 PM

Monday, January 26, 2015 12:13:19 PM

Post# of 821321
$PMCB News - PharmaCyte Biotech's Pancreatic Cancer Treatment Named as Near-Term Approach to Rising Pancreatic Cancer Rates

SILVER SPRING, Md., Jan 15, 2015 (GLOBE NEWSWIRE via COMTEX) -- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live cell encapsulation technology, Cell-in-a-Box, today announced that well-known scientific journalist, Vicki Brower, who writes for the leading top-tier cancer journals, has published an article naming PharmaCyte Biotech's pancreatic cancer treatment as a near-term approach to tackling the rising pancreatic cancer rates.
The article appeared in the December edition of the Journal of the National Cancer Institute prior to the Company's name change from Nuvilex to PharmaCyte Biotech. Brower's article is titled "New Approaches Tackle Rising Pancreatic Cancer Rates" and can be read in full at: http://jnci.oxfordjournals.org/content/106/12/dju417.full.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.